AI, Proteomics, and Advanced Analytics for Drug Development
-
Showcase the use of AI and machine learning to accelerate clinical research through disease understanding, patient stratification biomarker discovery and improved trial design.
-
Explore how proteomics, alongside genomics, imaging, is integrated in clinical data to uncover novel disease mechanisms and therapeutic targets.
-
Emphasize aligning scientific innovation with business needs to deliver actionable insights, foster strategic collaborations, and support data-informed decision-making across drug development.